nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—CHRM3—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0264	0.0264	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0261	0.0261	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0258	0.0258	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0256	0.0256	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0222	0.0222	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0219	0.0219	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0217	0.0217	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0215	0.0215	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0156	0.0156	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0155	0.0155	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.015	0.015	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0149	0.0149	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0145	0.0145	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0144	0.0144	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0141	0.0141	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0139	0.0139	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0138	0.0138	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0137	0.0137	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0137	0.0137	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0135	0.0135	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.0134	0.0134	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0131	0.0131	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.013	0.013	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0127	0.0127	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0126	0.0126	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0122	0.0122	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0121	0.0121	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0118	0.0118	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0117	0.0117	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0116	0.0116	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0115	0.0115	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0115	0.0115	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0114	0.0114	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0107	0.0107	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0106	0.0106	CbGpPWpGaD
Bethanechol—CHRM3—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0105	0.0105	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.00924	0.00924	CbGpPWpGaD
Bethanechol—CHRM3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00892	0.00892	CbGpPWpGaD
Bethanechol—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00883	0.00883	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.00845	0.00845	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00809	0.00809	CbGpPWpGaD
Bethanechol—CHRM3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0075	0.0075	CbGpPWpGaD
Bethanechol—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00743	0.00743	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00738	0.00738	CbGpPWpGaD
Bethanechol—CHRM3—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00726	0.00726	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00703	0.00703	CbGpPWpGaD
Bethanechol—CHRM3—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00664	0.00664	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00626	0.00626	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0062	0.0062	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00607	0.00607	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00601	0.00601	CbGpPWpGaD
Bethanechol—CHRM3—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00581	0.00581	CbGpPWpGaD
Bethanechol—CHRM3—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00553	0.00553	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00543	0.00543	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0052	0.0052	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00509	0.00509	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00504	0.00504	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00498	0.00498	CbGpPWpGaD
Bethanechol—CHRM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00498	0.00498	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00495	0.00495	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00493	0.00493	CbGpPWpGaD
Bethanechol—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00493	0.00493	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0049	0.0049	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00447	0.00447	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00436	0.00436	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00432	0.00432	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00427	0.00427	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00423	0.00423	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00416	0.00416	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00416	0.00416	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00396	0.00396	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00392	0.00392	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00369	0.00369	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00345	0.00345	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00342	0.00342	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00332	0.00332	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00329	0.00329	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00325	0.00325	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00322	0.00322	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00322	0.00322	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00313	0.00313	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00302	0.00302	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00302	0.00302	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00299	0.00299	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00296	0.00296	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00293	0.00293	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0029	0.0029	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00285	0.00285	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00282	0.00282	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00281	0.00281	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0028	0.0028	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00278	0.00278	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00277	0.00277	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00272	0.00272	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00269	0.00269	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00267	0.00267	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00265	0.00265	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00264	0.00264	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00262	0.00262	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00261	0.00261	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00259	0.00259	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00256	0.00256	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00255	0.00255	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00254	0.00254	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00251	0.00251	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00246	0.00246	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00243	0.00243	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0024	0.0024	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00238	0.00238	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00233	0.00233	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00231	0.00231	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00229	0.00229	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00227	0.00227	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00226	0.00226	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00225	0.00225	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00224	0.00224	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00223	0.00223	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00223	0.00223	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00211	0.00211	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00209	0.00209	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00197	0.00197	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00195	0.00195	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.00188	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00186	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00184	0.00184	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00183	0.00183	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00181	0.00181	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00177	0.00177	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00176	0.00176	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00173	0.00173	CbGpPWpGaD
Bethanechol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00172	0.00172	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00172	0.00172	CbGpPWpGaD
Bethanechol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0017	0.0017	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0017	0.0017	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0017	0.0017	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00167	0.00167	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00165	0.00165	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0016	0.0016	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00159	0.00159	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0015	0.0015	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00149	0.00149	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00148	0.00148	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00146	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00135	0.00135	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00127	0.00127	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00117	0.00117	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00116	0.00116	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00116	0.00116	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00115	0.00115	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00111	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00111	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0011	0.0011	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00103	0.00103	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00102	0.00102	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00101	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00101	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.001	0.001	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.001	0.001	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000996	0.000996	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000992	0.000992	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000986	0.000986	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000985	0.000985	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000976	0.000976	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000975	0.000975	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000973	0.000973	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000966	0.000966	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000963	0.000963	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000957	0.000957	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00094	0.00094	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000931	0.000931	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00091	0.00091	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000906	0.000906	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000901	0.000901	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000898	0.000898	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000895	0.000895	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000886	0.000886	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000883	0.000883	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000875	0.000875	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00083	0.00083	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00083	0.00083	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000823	0.000823	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000817	0.000817	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000815	0.000815	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000759	0.000759	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000683	0.000683	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000676	0.000676	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000664	0.000664	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000635	0.000635	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000632	0.000632	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000629	0.000629	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000597	0.000597	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000591	0.000591	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000576	0.000576	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000571	0.000571	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000555	0.000555	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00055	0.00055	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000538	0.000538	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000532	0.000532	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000528	0.000528	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000523	0.000523	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000522	0.000522	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000517	0.000517	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000503	0.000503	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0005	0.0005	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000486	0.000486	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000481	0.000481	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000341	0.000341	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000337	0.000337	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000216	0.000216	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00018	0.00018	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000179	0.000179	CbGpPWpGaD
